Related Experiment Video

Updated: Jun 22, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Role of depression in heart failure--choosing the right antidepressive treatment

Dimitris Tousoulis1, Alexis S Antonopoulos, Charalambos Antoniades

  • 1Athens University Medical School, 1st Cardiology Department, Greece. drtousoulis@hotmail.com

International Journal of Cardiology
|June 9, 2009
PubMed

Insights

Major depression is common in heart failure patients, sharing a biochemical background. Selective serotonin reuptake inhibitors may improve heart failure outcomes, though more research is needed.

Area of Science:

  • Cardiology
  • Psychiatry
  • Pharmacology

Background:

  • Major depression frequently co-occurs with heart failure, potentially due to shared biochemical pathways.
  • This comorbidity significantly impacts patient prognosis and treatment considerations.
  • Cardiovascular side effects of antidepressants complicate treatment choices in heart failure patients.

Purpose of the Study:

  • To highlight the role of major depression in heart failure.
  • To demonstrate the common biochemical background between depression and heart failure.
  • To review the efficacy and safety of various antidepressant categories in heart failure patients.

Main Methods:

  • Review of existing clinical studies on antidepressant use in heart failure.
  • Analysis of biochemical links between depression and heart failure.
  • Evaluation of cardiovascular safety and efficacy data for different antidepressant classes.

Main Results:

  • Evidence suggests selective serotonin reuptuptake inhibitors (SSRIs) may offer a beneficial effect on heart failure outcomes.
  • The safety and efficacy of most antidepressants in heart failure remain not fully elucidated.
  • A common biochemical background between major depression and heart failure is highlighted.

Conclusions:

  • The choice of antidepressant treatment is critical for heart failure patients and can influence clinical outcomes.
  • SSRIs show potential for improving clinical outcomes in heart failure patients.
  • Further research is necessary to fully establish the safety and efficacy of antidepressants in this population.

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...